Cargando…

Lysophosphatidic Acid Receptor Signaling in the Human Breast Cancer Tumor Microenvironment Elicits Receptor-Dependent Effects on Tumor Progression

Lysophosphatidic acid receptors (LPARs) are six G-protein-coupled receptors that mediate LPA signaling to promote tumorigenesis and therapy resistance in many cancer subtypes, including breast cancer. Individual-receptor-targeted monotherapies are under investigation, but receptor agonism or antagon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benesch, Matthew G. K., Wu, Rongrong, Tang, Xiaoyun, Brindley, David N., Ishikawa, Takashi, Takabe, Kazuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298074/ https://www.ncbi.nlm.nih.gov/pubmed/37372960 http://dx.doi.org/10.3390/ijms24129812

Ejemplares similares

Decreased Lipid Phosphate Phosphatase 1/3 and Increased Lipid Phosphate Phosphatase 2 Expression in the Human Breast Cancer Tumor Microenvironment Promotes Tumor Progression and Immune System Evasion
por: Benesch, Matthew G. K., et al.
Publicado: (2023)

Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer
por: Brindley, David N., et al.
Publicado: (2020)

Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivo
por: Benesch, Matthew G.K., et al.
Publicado: (2016)

Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation
por: Benesch, Matthew G.K., et al.
Publicado: (2018)

Intratumoral Tumor Infiltrating Lymphocytes (TILs) are Associated With Cell Proliferation and Better Survival But Not Always With Chemotherapy Response in Breast Cancer
por: Wu, Rongrong, et al.
Publicado: (2023)

Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor
por: Takeshita, Takashi, et al.
Publicado: (2019)

Lysophosphatidic Acid: Promoter of Cancer Progression and of Tumor Microenvironment Development. A Promising Target for Anticancer Therapies?
por: Aiello, Sistiana, et al.
Publicado: (2021)

Lysophosphatidic Acid Signaling in Cancer
por: Brindley, David N.
Publicado: (2020)

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)

Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment
por: Gandhi, Shipra, et al.
Publicado: (2021)

Genetic and Epigenetic Alterations of Lysophosphatidic Acid Receptor Genes in Rodent Tumors by Experimental Models
por: Tsujiuchi, Toshifumi, et al.
Publicado: (2011)

Types of Cancer and Research Covered in World Journal of Oncology
por: Takabe, Kazuaki, et al.
Publicado: (2022)

Biomarker Research in World Journal of Oncology
por: Takabe, Kazuaki, et al.
Publicado: (2023)

High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

Autotaxin and Breast Cancer: Towards Overcoming Treatment Barriers and Sequelae
por: Benesch, Matthew G. K., et al.
Publicado: (2020)

Development of a Machine Learning-Based Prognostic Model for Hormone Receptor-Positive Breast Cancer Using Nine-Gene Expression Signature
por: Takeshita, Takashi, et al.
Publicado: (2023)

Intravital microscopy in the study of the tumor microenvironment: from bench to human application
por: Gabriel, Emmanuel M., et al.
Publicado: (2018)

Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation
por: Tang, Xiaoyun, et al.
Publicado: (2017)

Lysophosphatidic acid in carcinogenesis and tumor development
por: Albrecht, Wiebke
Publicado: (2018)

Regulation of Tumor Immunity by Lysophosphatidic Acid
por: Lee, Sue Chin, et al.
Publicado: (2020)

Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017)

NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation
por: Wu, Rongrong, et al.
Publicado: (2022)

The role of glutamate receptors in the regulation of the tumor microenvironment
por: Koda, Stephane, et al.
Publicado: (2023)

Clinical Relevance of Estrogen Reactivity in the Breast Cancer Microenvironment
por: Takeshita, Takashi, et al.
Publicado: (2022)

Octogenarians’ Breast Cancer Is Associated with an Unfavorable Tumor Immune Microenvironment and Worse Disease-Free Survival
por: Okano, Maiko, et al.
Publicado: (2021)

The Dimensions of Reports From Around the World That Address Diversity in Oncology
por: Takabe, Kazuaki, et al.
Publicado: (2022)

World Journal of Oncology Has Gained an Impact Factor of 5.2 by Journal Citation Reports
por: Takabe, Kazuaki, et al.
Publicado: (2023)

Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
por: Kitayama, Joji, et al.
Publicado: (2004)

PDGFRα Enhanced Infection of Breast Cancer Cells with Human Cytomegalovirus but Infection of Fibroblasts Increased Prometastatic Inflammation Involving Lysophosphatidate Signaling
por: Yang, Zelei, et al.
Publicado: (2021)

Dexamethasone Attenuates X-Ray-Induced Activation of the Autotaxin-Lysophosphatidate-Inflammatory Cycle in Breast Tissue and Subsequent Breast Fibrosis
por: Meng, Guanmin, et al.
Publicado: (2020)

Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival
por: Oshi, Masanori, et al.
Publicado: (2021)

Enhancement of Drug Resistance by Lysophosphatidic Acid Receptor-3 in Mouse Mammary Tumor FM3A Cells
por: Fukui, Rie, et al.
Publicado: (2012)

Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis
por: Lin, Kuan-Hung, et al.
Publicado: (2016)

The Breast Tumor Microenvironment: Could Silicone Breast Implant Elicit Breast Carcinoma?
por: Fleury, Eduardo, et al.
Publicado: (2021)

Should we target “intermediate expression” of HER2 in older estrogen receptor positive patients?
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

Lysophosphatidic acid receptor 6 regulated by miR-27a-3p attenuates tumor proliferation in breast cancer
por: Lei, J., et al.
Publicado: (2021)

The Role of Chemoattractant Receptors in Shaping the Tumor Microenvironment
por: Zhou, Jiamin, et al.
Publicado: (2014)

Macrophages in Tumor Microenvironments and the Progression of Tumors
por: Hao, Ning-Bo, et al.
Publicado: (2012)

Repeated Fractions of X-Radiation to the Breast Fat Pads of Mice Augment Activation of the Autotaxin-Lysophosphatidate-Inflammatory Cycle
por: Meng, Guanmin, et al.
Publicado: (2019)

Lysophosphatidic acid-RAGE axis promotes lung and mammary oncogenesis via protein kinase B and regulating tumor microenvironment
por: Ray, Rashmi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pgldod00d4pvuit55f9mdlsh3e